Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/1/1994
1.
Phase III Randomized Double-Blind Study of Roquinimex vs Placebo Following ABMT for Acute Myeloid Leukemia in First or Subsequent Complete Remission (Summary Last Modified 10/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
10 to 65
PHARMACIA-T91-OL-01
UPCC-1491, URCC-4510, NCI-V93-0218
Last Modified:
4/26/2007
2.
A Phase II Pilot Study of Roquinimex in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 06/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 75
EORTC-30905
Last Modified:
7/1/1993
3.
Phase II Study of Roquinimex in the Treatment of Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 07/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
EORTC-30923
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute